Literature DB >> 28157624

An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function.

Bernice Nounamo1, Yibo Li1, Peter O'Byrne2, Aoife M Kearney2, Amir Khan3, Jia Liu4.   

Abstract

In humans, deleterious mutations in the sterile α motif domain protein 9 (SAMD9) gene are associated with cancer, inflammation, weakening of the immune response, and developmental arrest. However, the biological function of SAMD9 and its sequence-structure relationships remain to be characterized. Previously, we found that an essential host range factor, M062 protein from myxoma virus (MYXV), antagonized the function of human SAMD9. In this study, we examine the interaction between M062 and human SAMD9 to identify regions that are critical to SAMD9 function. We also characterize the in vitro kinetics of the interaction. In an infection assay, exogenous expression of SAMD9 N-terminus leads to a potent inhibition of wild-type MYXV infection. We reason that this effect is due to the sequestration of viral M062 by the exogenously expressed N-terminal SAMD9 region. Our studies reveal the first molecular insight into viral M062-dependent mechanisms that suppress human SAMD9-associated antiviral function.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C7L superfamily; Host range factor; Immunoprecipitation; MYXV; Polymerization; Protein-protein interaction; SAMD9; Surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2017        PMID: 28157624      PMCID: PMC5419587          DOI: 10.1016/j.virol.2017.01.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  The stress granule protein G3BP1 recruits protein kinase R to promote multiple innate immune antiviral responses.

Authors:  Lucas C Reineke; Richard E Lloyd
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

2.  Generation of genomic deletions in mammalian cell lines via CRISPR/Cas9.

Authors:  Daniel E Bauer; Matthew C Canver; Stuart H Orkin
Journal:  J Vis Exp       Date:  2015-01-03       Impact factor: 1.355

3.  SAMD9 is an innate antiviral host factor with stress response properties that can be antagonized by poxviruses.

Authors:  Jia Liu; Grant McFadden
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

4.  A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis.

Authors:  Orit Topaz; Margarita Indelman; Ilana Chefetz; Dan Geiger; Aryeh Metzker; Yoram Altschuler; Mordechai Choder; Dani Bercovich; Jouni Uitto; Reuven Bergman; Gabriele Richard; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2006-08-24       Impact factor: 11.025

5.  Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.

Authors:  Dov Hershkovitz; Yonit Gross; Sagi Nahum; Shiran Yehezkel; Ofer Sarig; Jouni Uitto; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

6.  Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins.

Authors:  Xiangzhi Meng; Brian Krumm; Yongchao Li; Junpeng Deng; Yan Xiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

7.  Comparative in vivo analysis of the nsp15 endoribonuclease of murine, porcine and severe acute respiratory syndrome coronaviruses.

Authors:  Jianzhong Cao; Xuming Zhang
Journal:  Virus Res       Date:  2012-05-19       Impact factor: 3.303

8.  Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.

Authors:  Catherine F Li; Jeffrey R MacDonald; Robert Y Wei; Jocelyn Ray; Kimberly Lau; Christopher Kandel; Rachel Koffman; Sherilyn Bell; Stephen W Scherer; Benjamin A Alman
Journal:  BMC Genomics       Date:  2007-04-03       Impact factor: 3.969

9.  RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules.

Authors:  N L Kedersha; M Gupta; W Li; I Miller; P Anderson
Journal:  J Cell Biol       Date:  1999-12-27       Impact factor: 10.539

10.  Large G3BP-induced granules trigger eIF2α phosphorylation.

Authors:  Lucas C Reineke; Jon D Dougherty; Philippe Pierre; Richard E Lloyd
Journal:  Mol Biol Cell       Date:  2012-07-25       Impact factor: 4.138

View more
  14 in total

1.  Multiorgan failure with abnormal receptor metabolism in mice mimicking Samd9/9L syndromes.

Authors:  Akiko Nagamachi; Akinori Kanai; Megumi Nakamura; Hiroshi Okuda; Akihiko Yokoyama; Satoru Shinriki; Hirotaka Matsui; Toshiya Inaba
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

2.  Identification of CP77 as the Third Orthopoxvirus SAMD9 and SAMD9L Inhibitor with Unique Specificity for a Rodent SAMD9L.

Authors:  Fushun Zhang; Xiangzhi Meng; Michael B Townsend; Panayampalli Subbian Satheshkumar; Yan Xiang
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

3.  Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.

Authors:  Sushree S Sahoo; Victor B Pastor; Charnise Goodings; Rebecca K Voss; Emilia J Kozyra; Amina Szvetnik; Peter Noellke; Michael Dworzak; Jan Starý; Franco Locatelli; Riccardo Masetti; Markus Schmugge; Barbara De Moerloose; Albert Catala; Krisztián Kállay; Dominik Turkiewicz; Henrik Hasle; Jochen Buechner; Kirsi Jahnukainen; Marek Ussowicz; Sophia Polychronopoulou; Owen P Smith; Oksana Fabri; Shlomit Barzilai; Valerie de Haas; Irith Baumann; Stephan Schwarz-Furlan; Marena R Niewisch; Martin G Sauer; Birgit Burkhardt; Peter Lang; Peter Bader; Rita Beier; Ingo Müller; Michael H Albert; Roland Meisel; Ansgar Schulz; Gunnar Cario; Pritam K Panda; Julius Wehrle; Shinsuke Hirabayashi; Marta Derecka; Robert Durruthy-Durruthy; Gudrun Göhring; Ayami Yoshimi-Noellke; Manching Ku; Dirk Lebrecht; Miriam Erlacher; Christian Flotho; Brigitte Strahm; Charlotte M Niemeyer; Marcin W Wlodarski
Journal:  Nat Med       Date:  2021-10-07       Impact factor: 87.241

4.  Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.

Authors:  Gilad Sivan; Shira G Glushakow-Smith; George C Katsafanas; Jeffrey L Americo; Bernard Moss
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 5.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

6.  Germline SAMD9L truncation variants trigger global translational repression.

Authors:  Troy R Torgerson; David J Rawlings; Eric J Allenspach; Frank Soveg; Laura S Finn; Lomon So; Jacquelyn A Gorman; Aaron B I Rosen; Suzanne Skoda-Smith; Marsha M Wheeler; Kaitlyn A Barrow; Lucille M Rich; Jason S Debley; Michael J Bamshad; Deborah A Nickerson; Ram Savan
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

7.  The complex domain architecture of SAMD9 family proteins, predicted STAND-like NTPases, suggests new links to inflammation and apoptosis.

Authors:  Sergei L Mekhedov; Kira S Makarova; Eugene V Koonin
Journal:  Biol Direct       Date:  2017-05-25       Impact factor: 4.540

Review 8.  Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.

Authors:  Sushree S Sahoo; Emilia J Kozyra; Marcin W Wlodarski
Journal:  Best Pract Res Clin Haematol       Date:  2020-07-29       Impact factor: 3.020

Review 9.  Lessons learned from the study of human inborn errors of innate immunity.

Authors:  Giorgia Bucciol; Leen Moens; Barbara Bosch; Xavier Bossuyt; Jean-Laurent Casanova; Anne Puel; Isabelle Meyts
Journal:  J Allergy Clin Immunol       Date:  2018-08-01       Impact factor: 10.793

Review 10.  COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints.

Authors:  Christopher C Goodnow
Journal:  Immunol Cell Biol       Date:  2020-11-23       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.